{"filing":{"accession_number":"0001522767-26-000164","cik":"0001522767","ticker":"MRMD","company_name":"MARIMED INC.","form":"8-K","filing_date":"2026-08-12","report_date":"2026-08-12","primary_document":"mrmd-20260812.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/mrmd-20260812.htm"},"events":[{"id":27350,"run_id":24918,"accession_number":"0001522767-26-000164","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"MariMed Inc. issued a press release on August 12, 2026 announcing its financial results for the three- and six-month periods ended June 30, 2026. The disclosure includes consolidated financial highlights showing revenue of $41.9M and $81.4M for Q2 and H1 2026 respectively, along with detailed operational metrics, management commentary, and condensed consolidated financial statements. This is a standard quarterly earnings release disclosure under Item 2.02.","company_name":"MARIMED INC.","ticker":"MRMD","filing_date":"2026-08-12","form":"8-K","submitted_at":null,"items":[{"id":28851,"accession_number":"0001522767-26-000164","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MariMed Inc. issued a press release on August 12, 2026 announcing its financial results for the three- and six-month periods ended June 30, 2026. The disclosure includes consolidated financial highlights showing revenue of $41.9M and $81.4M for Q2 and H1 2026 respectively, along with detailed operational metrics, management commentary, and condensed consolidated financial statements. This is a standard quarterly earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T21:09:37.507126+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28851,"accession_number":"0001522767-26-000164","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MariMed Inc. issued a press release on August 12, 2026 announcing its financial results for the three- and six-month periods ended June 30, 2026. The disclosure includes consolidated financial highlights showing revenue of $41.9M and $81.4M for Q2 and H1 2026 respectively, along with detailed operational metrics, management commentary, and condensed consolidated financial statements. This is a standard quarterly earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T21:09:37.507126+00:00","company_name":"MARIMED INC.","ticker":"MRMD","filing_date":"2026-08-12"}]}